<DOC>
	<DOCNO>NCT00385944</DOCNO>
	<brief_summary>This multicenter , randomize , double-blind , cross-over study compare pharmacodynamic response subject Acute Coronary Syndrome receive 10-mg maintenance dose ( MD ) prasugrel compare 150-mg maintenance dose clopidogrel , follow 900-mg load dose ( LD ) clopidogrel .</brief_summary>
	<brief_title>The Effect Blood Cells , Known Platelets , Using Prasugrel v Clopidogrel Patients With Heart Problem Acute Coronary Syndrome ( ACS )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<criteria>Present acute coronary syndrome ( ACS ) plan treatment onetime 900mg load dose commercially available clopidogrel ( administer single cumulative dose ) . Are age 18 85 year . Willing able sign inform consent . Have overt STsegment elevation myocardial infarction ( STEMI ) . Have cardiogenic shock . Have refractory ventricular arrhythmia . Have New York Heart Association ( NYHA ) Class IV congestive heart failure . Have severe uncontrolled hypertension . Have active internal bleeding history bleed diathesis . Have increase risk bleeding . Have history cerebrovascular accident . Have certain abnormal blood level value . Are currently receive chemotherapy radiation therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>